Company / EPS (Basic)
IRONWOOD PHARMACEUTICALS INC EPS (Basic) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$0.01
FY2025
5-year range
$0.01 / $3.26
FY2021-FY2025
Trend
-99.1%
vs FY2024
Sector context
#49 of 208
Health Care
What the data says
IRONWOOD PHARMACEUTICALS INC's eps (basic) of $0.01 is higher than 76% of companies in the Health Care sector (FY2025). Declined from $3.26 to $0.01 over the past 2 years.
Based on SEC 10-K filings.
0.01 in FY2025 with a 3-year CAGR of -75.4%. Top quartile in the Health Care sector.
Declined from $3.26 to $0.01 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -75.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 208This company $0.01 Sector average -$0.96
▼
+101.0% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) decreased 99.1% year-over-year.
- Ranks #49 out of 208 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2023.
- Lowest eps (basic) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -99.1% |
| FY2024 | $1.13 | -65.3% |
| FY2023 | $3.26 | +386.6% |
| FY2022 | $0.67 | +378.6% |
| FY2021 | $0.14 | +107.6% |
| FY2020 | -$1.85 | -386.8% |
| FY2019 | -$0.38 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026